Salivary VEGF: A non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication

International Archives of Medicine

Volumn 2, Issue 1, 2009, Pages

  Upile, Tahwinder ^a,b,c   Jerjes, Waseem ^b,c   Kafas, Panagiotis ^d   Harini, Shash ^a   Singh, Sandeep U ^a,b   Guyer, Marcel ^a   Bentley, Melissa ^a   Sudhoff, Holger ^e   Hopper, Colin ^b,c  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN 165; VASCULOTROPIN A;

ARTICLE; BLOOD SAMPLING; BODY FLUID COMPARTMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LYMPH VESSEL ENDOTHELIUM; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SALIVA; SALIVA ANALYSIS; VASCULAR ENDOTHELIUM;

EID: 70449688641     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-2-12     Document Type: Article

References (9)

1. Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. NS Taichman AT Cruchley LM Fletcher EP Hagi-Pavli EM Paleolog WR Abrams V Booth RM Edwards D Malamud, Lab Invest 1998 78 7 869 75 9690564 (Pubitemid 28347883)
2. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. N Tzanakis M Gazouli G Rallis G Giannopoulos I Papaconstantinou G Theodoropoulos E Pikoulis C Tsigris P Karakitsos G Peros N Nikiteas, J Surg Oncol 2006 94 7 624 630 10.1002/jso.20619 17111394
3. Correlational of oral tongue cancer inversion with matrix metalloproteinases. MS Lim, J Surg Oncol 2006 93 4 253 4 10.1002/jso.20462 16496361
4. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pammer W Weninger M Mildner M Burian J Wojta E Tschachler, J Pathol 1998 186 2 186 91 10.1002/(SICI)1096-9896(1998100)186:2<186::AID-PATH148>3.0.CO;2-J 9924435 (Pubitemid 28467829)
5. Vascular endothelial growth factor in human periodontal disease. V Booth S Young A Cruchley NS Taichman E Paleolog, J Periodontal Res 1998 33 8 491 9 9879523 (Pubitemid 128527352)
6. Salivary levels of vascular endothelial growth factor (VEGF) in recurrent aphthous ulceration. S Brozovic V Vucicevic-Boras M Mravak-Stipetic S Jukic J Kleinheinz J Lukac, J Oral Pathol Med 2002 31 2 106 8 10.1034/j.1600-0714.2002. 310208.x 11896832 (Pubitemid 34535996)
7. Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. C Caccamo L Nostro G Giorgianni S Mondello E Crasc N Frisina M Buemi, J Reprod Med 2007 52 11 1035 9 18161402 (Pubitemid 350305087)
8. The uncertainty of the surgical margin in the treatment of head and neck cancer. T Upile C Fisher W Jerjes M El Maaytah A Searle D Archer L Michaels P Rhys-Evans C Hopper D Howard A Wright, Oral Oncol 2007 43 4 321 6 10.1016/j.oraloncology.2006.08.002 17112772 (Pubitemid 46413990)
9. Saliva as a biomarker for head and neck squamous cell carcinoma: in vitro detection of cytotoxic effects by using the plating efficiency index. MB Bloching J Barnes W Aust S Knipping K Neumann T Grummt R Naim, Oncol Rep 2007 18 6 1551 6 17982643